Acasti Pharma Inc operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Acasti Pharma Inc with three other companies in this sector in Canada: CO2 GRO Inc (2016 sales of 7,925.00 Canadian Dollars [US$5,958.65 ] ), Novoheart Holdings Inc (10,150.00 Canadian Dollars [US$7,631.58 ] ), and Pacgen Life Science Corporation (65,611.00 Canadian Dollars [US$49,331.60 ] ).

Sales Analysis. Sales fell dramatically in 2016: During the year ended March of 2016, sales at Acasti Pharma Inc were C$37,656.00 (US$28.31 thousand). This is a sharp decrease of 86.1% versus 2015, when the company's sales were C$270,615.00 .